SEC 13F Intelligence

Managers / Q1 2026

Simplify Asset Management Inc.

CIK 0001846368 · 10845 GRIFFITH PEAK DRIVE, 2/F, LAS VEGAS, NV, 89135 · 646-741-2438

Reported Value
$6.5B
Q1 2026
Positions
143
Filings on Record
23
2019–present window
Filed
Apr 27, 2026
original filing

Summary

Simplify Asset Management Inc. reported $6.5B in U.S.-listed holdings across 143 positions for Q1 2026.

The portfolio is heavily concentrated: Simplify Exchange Traded Fun alone accounts for 70.7% of reported value.

Compared with Q4 2025, the fund opened 35 new positions and exited 34.

Portfolio Metrics

Turnover
+3.9%
vs prior filed quarter
Top-10 Concentration
+93.8%
share of reported value
Largest Position
+70.7%
Simplify Exchange Traded Fun
New / Exited
35 / 34
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $110MQ4 ’20Q1 ’21: $249MQ2 ’21: $667MQ3 ’21: $1.4BQ3 ’21Q4 ’21: $2.3BQ1 ’22: $3.1BQ2 ’22: $2.6BQ2 ’22Q3 ’22: $941MQ4 ’22: $649MQ1 ’23: $697MQ1 ’23Q2 ’23: $760MQ3 ’23: $875MQ4 ’23: $1.1BQ4 ’23Q1 ’24: $1.7BQ2 ’24: $1.5BQ3 ’24: $2.1BQ3 ’24Q4 ’24: $2.0BQ1 ’25: $2.7BQ2 ’25: $2.0BQ2 ’25Q3 ’25: $5.4BQ4 ’25: $6.1BQ1 ’26: $6.5BQ1 ’26filingsflow.com

Portfolio Composition

By security type
ETP: 95.1%Common Stock: 4.1%Other: 0.4%ADR: 0.2%REIT: 0.2%Other: 0.0%
  • ETP · 95.1% · $6.2B
  • Common Stock · 4.1% · $268M
  • Other · 0.4% · $28M
  • ADR · 0.2% · $14M
  • REIT · 0.2% · $10M
  • Other · 0.0% · $978,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SIMPLIFY EXCHANGE TRADED FUNNEW+5.53M5.53M+$117M$117M
SIMPLIFY EXCHANGE TRADED FUNNEW+1.70M1.70M+$40M$40M
NVONOVO-NORDISK A SNEW+327.4K327.4K+$12M$12M
ASTRAZENECA PLCNEW+25.8K25.8K+$5M$5M
SIMPLIFY EXCHANGE TRADED FUNNEW+151.4K151.4K+$5M$5M
HTDCORCEPT THERAPEUTICS INCNEW+37.8K37.8K+$2M$2M
BRK/BBERKSHIRE HATHAWAY INC DELNEW+2.6K2.6K+$1M$1M
OXLCOXFORD LANE CAP CORPNEW+100.0K100.0K+$978,000$978,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

36 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1SIMPLIFY EXCHANGE TRADED FUNGOVERNMENT MONEY · SHORT TERM TREA · US EQT PLS UPSID · MULTI QIS ALTERN · AGGREGATE BOND E · TREASURY OPT INC · NATL MUNI BD ETF · NEXT INTANGIBLE · TARGET 15 DISTRI · MANAGED FUTURES · ANCORATO TARGET · US EQUITY PLUS M · PIPER SANDLER US76.94%$5.0B64.26M
2ISHARES TRCORE S&P500 ETF · CORE US AGGBD ET17.20%$1.1B5.19M
3PAGPEURPLAINS GP HLDGS L Phistory →LTD PARTNR INT A0.47%$31M1.27M
4IBITISHARES BITCOIN TRUST ETFhistory →SHS BEN INT0.41%$27M700.0K
5UTHUNITED THERAPEUTICS CORP DELhistory →COM0.31%$20M34.3K
6AFWALIGN TECHNOLOGY INChistory →COM0.28%$18M106.9K
7LLYELI LILLY & COhistory →COM0.24%$15M16.7K
8NVONOVO-NORDISK A Shistory →ADR0.18%$12M327.4K
9ABBVABBVIE INChistory →COM0.16%$11M48.6K
10JAZZ PHARMACEUTICALS PLCSHS USD0.15%$10M51.7K
11PCTPURECYCLE TECHNOLOGIES INCCOM0.14%$9M1.77M
12TMOTHERMO FISHER SCIENTIFIC INCCOM0.13%$9M17.4K
13GILDGILEAD SCIENCES INCCOM0.13%$9M61.3K
14REGNREGENERON PHARMACEUTICALSCOM0.13%$8M10.9K
15JNJJOHNSON & JOHNSONCOM0.12%$8M33.1K
16BIOHAVEN LTDCOM0.12%$8M898.4K
17TXG10X GENOMICS INCCL A COM0.12%$8M354.7K
18MMM3M COCOM0.10%$6M44.2K
19WRBYWARBY PARKER INCCL A COM0.09%$6M290.8K
20DHRDANAHER CORP DELCOM0.09%$6M32.3K
21BNTCBENITEC BIOPHARMA INCCOM NEW0.09%$6M562.2K
22AMGNAMGEN INCCOM0.09%$6M15.8K
23ASTRAZENECA PLCORD0.08%$5M25.8K
24ISRGINTUITIVE SURGICAL INCCOM NEW0.08%$5M10.8K
25EYPTEYEPOINT INCCOM NEW0.06%$4M326.1K
26TSLATESLA INCCOM0.06%$4M11.1K
27HODLVANECK BITCOIN ETFSH BEN INT0.06%$4M209.2K
28CVSCVS HEALTH CORPCOM0.06%$4M54.0K
29VRTXVERTEX PHARMACEUTICALS INCCOM0.05%$4M7.9K
30SP4PACHIEVE LIFE SCIENCE INCCOM0.05%$3M1.18M
31ALHCALIGNMENT HEALTHCARE INCCOM0.05%$3M193.0K
32RITMRITHM CAPITAL CORPCOM NEW0.05%$3M336.6K
33ESTABLISHMENT LABS HLDGS INCCOM0.05%$3M53.0K
34PHATPHATHOM PHARMACEUTICALS INCCOM0.04%$3M262.4K
35GEHCGE HEALTHCARE TECHNOLOGIES ICOMMON STOCK0.04%$3M39.3K
36DCTHDELCATH SYS INCCOM NEW0.04%$2M261.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$6.5B143Apr 27, 202613F-HRchanges · EDGAR ↗
Q4 2025$6.1B142Feb 9, 202613F-HRchanges · EDGAR ↗
Q3 2025$5.4B129Oct 20, 202513F-HRchanges · EDGAR ↗
Q2 2025$2.0B89Aug 7, 202513F-HRchanges · EDGAR ↗
Q1 2025$2.7B94May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$2.0B92Feb 11, 202513F-HRchanges · EDGAR ↗
Q3 2024$2.1B106Nov 12, 2024RESTATEMENTchanges · EDGAR ↗
Q2 2024$1.5B109Aug 12, 202413F-HRchanges · EDGAR ↗
Q1 2024$1.7B103May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.1B115Feb 12, 202413F-HRchanges · EDGAR ↗
Q3 2023$875M122Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$760M113Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$697M119May 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$649M78Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$941M74Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$2.6B74Aug 11, 202213F-HRchanges · EDGAR ↗
Q1 2022$3.1B93May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$2.3B73Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.4B38Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$667M24Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$249M10May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$110M52Feb 16, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.